Literature DB >> 31563425

Patient Reported Outcomes Have Arrived: A Practical Overview for Clinicians in Using Patient Reported Outcomes in Oncology.

Rahma Warsame1, Anita D'Souza2.   

Abstract

Ensuring that the patient's voice is routinely incorporated in all aspects of health care in oncology is essential to provide quality care. Patient reported outcomes (PROs) are standardized measures that are used to obtain the patient's perspective and are increasingly used in all aspects of health care to ensure optimal delivery of patient-centered care. The US Food and Drug Administration encourages that PROs be used in studies for label indications. There are no uniform standardized methods to use PROs nor is there consensus on which PROs are best for regulatory approval, comparative effectiveness research, toxicity assessment, health-related quality of life, or symptom monitoring. For this review, we conducted a literature search using PubMed and Google Scholar, and herein summarize the evidence related to the use of PROs in clinic care and research. Using valid, reliable, and easily interpretable PROs developed in comparable populations will provide the most useful results. Various ways that PROs can be used successfully in oncology have been exemplified in this overview to provide clinicians and researchers practical guidance.
Copyright © 2019 Mayo Foundation for Medical Education and Research. Published by Elsevier Inc. All rights reserved.

Entities:  

Year:  2019        PMID: 31563425      PMCID: PMC6832764          DOI: 10.1016/j.mayocp.2019.04.005

Source DB:  PubMed          Journal:  Mayo Clin Proc        ISSN: 0025-6196            Impact factor:   7.616


  55 in total

1.  Medscape's response to the Institute of Medicine Report: Crossing the quality chasm: a new health system for the 21st century.

Authors:  M Leavitt
Journal:  MedGenMed       Date:  2001-03-05

2.  End points and trial design in geriatric oncology research: a joint European organisation for research and treatment of cancer--Alliance for Clinical Trials in Oncology--International Society Of Geriatric Oncology position article.

Authors:  Hans Wildiers; Murielle Mauer; Athanasios Pallis; Arti Hurria; Supriya G Mohile; Andrea Luciani; Giuseppe Curigliano; Martine Extermann; Stuart M Lichtman; Karla Ballman; Harvey Jay Cohen; Hyman Muss; Ulrich Wedding
Journal:  J Clin Oncol       Date:  2013-09-09       Impact factor: 44.544

3.  Use of patient-reported outcomes in clinical practice.

Authors:  Claire F Snyder; Neil K Aaronson
Journal:  Lancet       Date:  2009-08-01       Impact factor: 79.321

4.  Centralized patient-reported outcome data collection in transplantation is feasible and clinically meaningful.

Authors:  Bronwen E Shaw; Ruta Brazauskas; Heather R Millard; Rachel Fonstad; Kathryn E Flynn; Amy Abernethy; Jenny Vogel; Charney Petroske; Deborah Mattila; Rebecca Drexler; Stephanie J Lee; Mary M Horowitz; J Douglas Rizzo
Journal:  Cancer       Date:  2017-08-17       Impact factor: 6.860

Review 5.  Implementing patient-reported outcomes assessment in clinical practice: a review of the options and considerations.

Authors:  Claire F Snyder; Neil K Aaronson; Ali K Choucair; Thomas E Elliott; Joanne Greenhalgh; Michele Y Halyard; Rachel Hess; Deborah M Miller; Bryce B Reeve; Maria Santana
Journal:  Qual Life Res       Date:  2011-11-03       Impact factor: 4.147

6.  A Review of Patient-Reported Outcome Labeling in the United States (2011-2015).

Authors:  Ari Gnanasakthy; Margaret Mordin; Emily Evans; Lynda Doward; Carla DeMuro
Journal:  Value Health       Date:  2016-12-02       Impact factor: 5.725

Review 7.  Patient-reported outcomes and the evolution of adverse event reporting in oncology.

Authors:  Andy Trotti; A Dimitrios Colevas; Ann Setser; Ethan Basch
Journal:  J Clin Oncol       Date:  2007-11-10       Impact factor: 44.544

8.  The effects of antihypertensive therapy on the quality of life.

Authors:  S H Croog; S Levine; M A Testa; B Brown; C J Bulpitt; C D Jenkins; G L Klerman; G H Williams
Journal:  N Engl J Med       Date:  1986-06-26       Impact factor: 91.245

9.  Patient-physician disagreement regarding performance status is associated with worse survivorship in patients with advanced cancer.

Authors:  Ian D Schnadig; Erik K Fromme; Charles L Loprinzi; Jeff A Sloan; Motomi Mori; Hong Li; Tomasz M Beer
Journal:  Cancer       Date:  2008-10-15       Impact factor: 6.860

10.  Patient-Reported Outcomes Labeling for Products Approved by the Office of Hematology and Oncology Products of the US Food and Drug Administration (2010-2014).

Authors:  Ari Gnanasakthy; Carla DeMuro; Marci Clark; Emily Haydysch; Esprit Ma; Vijayveer Bonthapally
Journal:  J Clin Oncol       Date:  2016-04-11       Impact factor: 44.544

View more
  20 in total

Review 1.  Innovations in research and clinical care using patient-generated health data.

Authors:  Heather S L Jim; Aasha I Hoogland; Naomi C Brownstein; Anna Barata; Adam P Dicker; Hans Knoop; Brian D Gonzalez; Randa Perkins; Dana Rollison; Scott M Gilbert; Ronica Nanda; Anders Berglund; Ross Mitchell; Peter A S Johnstone
Journal:  CA Cancer J Clin       Date:  2020-04-20       Impact factor: 508.702

2.  A systematic review of patient-reported outcome measures in paediatric endocrinology.

Authors:  Richard G McGee; Edward Y B Zhang; Jennifer J G Tan; Aiden C K Cheung; Matthew P Garvey
Journal:  BMC Endocr Disord       Date:  2022-07-15       Impact factor: 3.263

3.  A catalyst for transforming health systems and person-centred care: Canadian national position statement on patient-reported outcomes.

Authors:  S Ahmed; L Barbera; S J Bartlett; D G Bebb; M Brundage; S Bryan; W Y Cheung; N Coburn; T Crump; L Cuthbertson; D Howell; A F Klassen; S Leduc; M Li; N E Mayo; G McKinnon; R Olson; J Pink; J W Robinson; M J Santana; R Sawatzky; R S Moxam; S Sinclair; F Servidio-Italiano; W Temple
Journal:  Curr Oncol       Date:  2020-05-01       Impact factor: 3.677

4.  Symptom burden in patients with common cancers near end-of-life and its associations with clinical characteristics: a real-world study.

Authors:  Atul Batra; Lin Yang; Devon J Boyne; Andrew Harper; Colleen A Cuthbert; Winson Y Cheung
Journal:  Support Care Cancer       Date:  2020-10-26       Impact factor: 3.603

5.  How Did a Multi-Institutional Trial Show Feasibility of Electronic Data Capture in Older Patients With Cancer? Results From a Multi-Institutional Qualitative Study (Alliance A171902).

Authors:  Nichole A Martin; Elizabeth S Harlos; Kathryn D Cook; Jennifer M O'Connor; Andrew Dodge; Emily Guerard; Jacqueline M Lafky; Aminah Jatoi; Jennifer G Le-Rademacher
Journal:  JCO Clin Cancer Inform       Date:  2021-04

6.  Changes in patient-reported outcomes in light chain amyloidosis in the first year after diagnosis and relationship to NT-proBNP change.

Authors:  Anita D'Souza; Ruta Brazauskas; Angela Dispenzieri; Julie Panepinto; Kathryn E Flynn
Journal:  Blood Cancer J       Date:  2021-02-01       Impact factor: 11.037

Review 7.  Efficacy and Safety of First-line Systemic Therapy for Metastatic Renal Cell Carcinoma: A Systematic Review and Network Meta-analysis.

Authors:  Nicholas A Bosma; Matthew T Warkentin; Chun Loo Gan; Safiya Karim; Daniel Y C Heng; Darren R Brenner; Richard M Lee-Ying
Journal:  Eur Urol Open Sci       Date:  2022-01-22

Review 8.  Patient generated health data and electronic health record integration in oncologic surgery: A call for artificial intelligence and machine learning.

Authors:  Laleh G Melstrom; Andrei S Rodin; Lorenzo A Rossi; Paul Fu; Yuman Fong; Virginia Sun
Journal:  J Surg Oncol       Date:  2020-09-24       Impact factor: 3.454

9.  Development of a conceptual model of patient-reported outcomes in light chain amyloidosis: a qualitative study.

Authors:  Anita D'Souza; Judith Myers; Rachel Cusatis; Angela Dispenzieri; Muriel Finkel; Julie Panepinto; Kathryn E Flynn
Journal:  Qual Life Res       Date:  2021-07-13       Impact factor: 4.147

10.  Protocol of a multicentric prospective cohort study for the VALIDation of the IBD-disk instrument for assessing disability in inflammatory bowel diseases: the VALIDate study.

Authors:  C Le Berre; A Bourreille; M Flamant; G Bouguen; L Siproudhis; M Dewitte; N Dib; E Cesbron-Metivier; T Goronflot; M Hanf; P-A Gourraud; E Kerdreux; A Poinas; C Trang-Poisson
Journal:  BMC Gastroenterol       Date:  2020-04-16       Impact factor: 3.067

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.